These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde. Lima VA; do Nascimento LA; Eliezer D; Follmer C ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158 [TBL] [Abstract][Full Text] [Related]
9. In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease. da Silva ANR; Pereira GRC; Bonet LFS; Outeiro TF; De Mesquita JF J Cell Biochem; 2024 Mar; 125(3):e30523. PubMed ID: 38239037 [TBL] [Abstract][Full Text] [Related]
10. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements. Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594 [TBL] [Abstract][Full Text] [Related]
11. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein. Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140 [TBL] [Abstract][Full Text] [Related]
12. Fibrillation of α-synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N-terminal acetylation and familial Parkinson's disease mutations. Monteiro Neto JR; Lima VA; Follmer C FEBS J; 2024 Mar; 291(6):1151-1167. PubMed ID: 38069536 [TBL] [Abstract][Full Text] [Related]
13. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo. Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807 [TBL] [Abstract][Full Text] [Related]
15. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease. Gonçalves SA; Outeiro TF Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512 [TBL] [Abstract][Full Text] [Related]
16. Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Masaracchia C; Hnida M; Gerhardt E; Lopes da Fonseca T; Villar-Pique A; Branco T; Stahlberg MA; Dean C; Fernández CO; Milosevic I; Outeiro TF Acta Neuropathol Commun; 2018 Aug; 6(1):79. PubMed ID: 30107856 [TBL] [Abstract][Full Text] [Related]
18. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response. Delaidelli A; Richner M; Jiang L; van der Laan A; Bergholdt Jul Christiansen I; Ferreira N; Nyengaard JR; Vægter CB; Jensen PH; Mackenzie IR; Sorensen PH; Jan A Acta Neuropathol Commun; 2021 Jun; 9(1):105. PubMed ID: 34092244 [TBL] [Abstract][Full Text] [Related]
19. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease. Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514 [TBL] [Abstract][Full Text] [Related]
20. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]